Dendritic cell derived exosomes loaded with immunoregulatory cargo reprogram local immune responses and inhibit degenerative bone disease in vivo

References

• Eke PI, Dye BA, Wei L, et al. Update on prevalence of Periodontitis in Adults in the USA: NHANES 2009 to 2012. J Periodontol. 2015;86:611–16. published online EpubMay.
   PubMed Web of Science ®Google Scholar
• Carrion J, Scisci E, Miles B, et al., Microbial carriage state of peripheral blood dendritic cells (DCs) in chronic periodontitis influences DC differentiation, atherogenic potential. J Immunol 189, 3178–3187; published online Epub Sep 15 (). 2012
   PubMed Web of Science ®Google Scholar
• Teixeira FB, Saito MT, Matheus FC, et al. Periodontitis and Alzheimer’s disease: a possible comorbidity between oral chronic inflammatory condition and neuroinflammation. Front Aging Neurosci. 2017;9:327.
   Web of Science ®Google Scholar
• Bartold PM, Van Dyke TE. An appraisal of the role of specific bacteria in the initial pathogenesis of periodontitis. J Clin Periodontol. 2019 Jan;46:6–11. published online Epub.
   Web of Science ®Google Scholar
• Jotwani R, Cutler CW. Multiple dendritic cell (DC) subpopulations in human gingiva and association of mature DCs with CD4+ T-cells in situ. J Dent Res. 2003 Sep;82:736–741. published online Epub. .
   Web of Science ®Google Scholar
• Jotwani R, Muthukuru M, Cutler CW. Increase in HIV receptors/co-receptors/alpha-defensins in inflamed human gingiva. J Dent Res. 2004 May;83:371–377. published online Epub. .
   PubMed Web of Science ®Google Scholar
• Jotwani R, Palucka AK, Al-Quotub M, et al. Mature dendritic cells infiltrate the T cell-rich region of oral mucosa in chronic periodontitis: in situ, in vivo, and in vitro studies. J Immunol. 2001 Oct 15 published online Epub;167: 4693–4700.
   PubMed Web of Science ®Google Scholar
• Arjunan P, Meghil MM, Pi W, et al. Oral Pathobiont activates anti-apoptotic pathway, promoting both immune suppression and oncogenic cell proliferation. Sci Rep. 2018 Nov 9;8:16607.
   Web of Science ®Google Scholar
• Barone F, Bombardieri M, Manzo A, et al. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren’s syndrome. Arthritis Rheum. 2005 Jun;52:1773–1784. published online Epub.
   PubMed Web of Science ®Google Scholar
• Bergomas F, Grizzi F, Doni A, et al. Tertiary intratumor lymphoid tissue in colo-rectal cancer. Cancers (Basel). 2011 Dec 28;4:1–10.
   Google Scholar
• Dudek AM, Martin S, Garg AD, et al. Immature, semi-mature, and fully mature dendritic cells: toward a dc-cancer cells interface that augments anticancer immunity. Front Immunol. 2013;4:438.
   PubMed Web of Science ®Google Scholar
• Park SJ, Nakagawa T, Kitamura H, et al. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol. 2004 Sep 15 published online Epub;173: 3844–3854.
   PubMed Web of Science ®Google Scholar
• Tsukasaki M, Komatsu N, Nagashima K, et al. Host defense against oral microbiota by bone-damaging T cells. Nat Commun. 2018 Feb 16;9:701.
   Web of Science ®Google Scholar
• Horton C, Shanmugarajah K, Fairchild PJ. Harnessing the properties of dendritic cells in the pursuit of immunological tolerance. Biomed J. 2017 Apr;40:80–93. published online Epub.
   PubMed Web of Science ®Google Scholar
• Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med. 2000 Nov 6;192:1213–1222.
   PubMed Web of Science ®Google Scholar
• Idoyaga J, Fiorese C, Zbytnuik L, et al. Specialized role of migratory dendritic cells in peripheral tolerance induction. J Clin Invest. 2013 Feb;123:844–854. published online Epub.
   PubMed Web of Science ®Google Scholar
• Hasegawa H, Matsumoto T. Mechanisms of tolerance induction by Dendritic cells in vivo. Front Immunol. 2018;9:350.
   PubMed Web of Science ®Google Scholar
• Komatsu N, Takayanagi H. Immune-bone interplay in the structural damage in rheumatoid arthritis. Clin Exp Immunol. 2018;194:1–8.
   Web of Science ®Google Scholar
• Dutzan N, Kajikawa T, Abusleme L, et al. A dysbiotic microbiome triggers TH17 cells to mediate oral mucosal immunopathology in mice and humans. Sci Transl Med. 2018 Oct 17;10:eaat0797.
   Web of Science ®Google Scholar
• Garlet GP, Cardoso CR, Mariano FS, et al. Regulatory T cells attenuate experimental periodontitis progression in mice. J Clin Periodontol. 2010 Jul;37:591–600. published online Epub.
   Web of Science ®Google Scholar
• Glowacki AJ, Yoshizawa S, Jhunjhunwala S, et al. Prevention of inflammation-mediated bone loss in murine and canine periodontal disease via recruitment of regulatory lymphocytes. Proc Natl Acad Sci U S A. 2013 Nov 12;110:18525–18530.
   PubMed Web of Science ®Google Scholar
• Rajendran M, Looney S, Singh N, et al. Systemic antibiotic therapy reduces circulating inflammatory Dendritic cells and Treg-Th17 plasticity in Periodontitis. J Immunol. 2019 May 1;202:2690–2699.
   Web of Science ®Google Scholar
• Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation. Semin Immunol. 2011 Aug;23:252–263. published online Epub.
   PubMed Web of Science ®Google Scholar
• Kim SH, Lechman ER, Bianco N, et al. Exosomes derived from IL-10-treated dendritic cells can suppress inflammation and collagen-induced arthritis. J Immunol (Baltimore, Md: 1950). 2005 May 15;174:6440–6448.
   PubMed Web of Science ®Google Scholar
• Clayton A, Harris CL, Court J, et al. Antigen-presenting cell exosomes are protected from complement-mediated lysis by expression of CD55 and CD59. Eur J Immunol. 2003 Feb;33:522–531. published online Epub.
   PubMed Web of Science ®Google Scholar
• Mentkowski KI, Snitzer JD, Rusnak S, et al. Therapeutic potential of engineered extracellular vesicles. Aaps J. 2018 Mar 15;20:50.
   PubMed Web of Science ®Google Scholar
• Haney MJ, Klyachko NL, Zhao Y, et al. Exosomes as drug delivery vehicles for Parkinson’s disease therapy. J Control Release. 2015 Jun 10;207:18–30.
   PubMed Web of Science ®Google Scholar
• Qazi KR, Gehrmann U, Domange Jordo E, et al. Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism. Blood. 2009 Mar 19;113:2673–2683.
   PubMed Web of Science ®Google Scholar
• Kim MS, Haney MJ, Zhao Y, et al. Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells. Nanomed. 2016 Apr;12:655–664. published online Epub.
   PubMed Web of Science ®Google Scholar
• Segura E, Valladeau-Guilemond J, Donnadieu MH, et al. Characterization of resident and migratory dendritic cells in human lymph nodes. J Exp Med. 2012 Apr 9;209:653–660.
   PubMed Web of Science ®Google Scholar
• Yin W, Ouyang S, Li Y, et al. Immature dendritic cell-derived exosomes: a promise subcellular vaccine for autoimmunity. Inflammation. 2013 Feb;36:232–240. published online Epub.
   PubMed Web of Science ®Google Scholar
• Muccioli M, Pate M, Omosebi O, et al. Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies. J Vis Exp. 2011 Jun 2. published online Epub. DOI:10.3791/2785
   Web of Science ®Google Scholar
• Helwa I, Cai J, Drewry MD, et al. A comparative study of serum exosome isolation using differential ultracentrifugation and three commercial reagents. PLOS One. 2017;12:e0170628.
   Google Scholar
• Mehdiani A, Maier A, Pinto A, et al. An innovative method for exosome quantification and size measurement. J Vis Exp. 2015 Jan 17:50974 published online Epub. DOI:10.3791/50974.
   Web of Science ®Google Scholar
• Dinkins MB, Enasko J. Neutral Sphingomyelinase-2 deficiency Ameliorates Alzheimer’s Disease pathology and improves cognition in the 5XFAD Mouse. J Neurosci. 2016 Aug 17;36:8653–8667. published online Epub.
   Google Scholar
• Wang Y, Zhang L, Li Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015 Aug 1;192:61–69.
   PubMed Web of Science ®Google Scholar
• Nirvani M, Khuu C, Utheim TP, et al. Circadian rhythms and gene expression during mouse molar tooth development. Acta Odontol Scand. 2017 Mar;75:144–153. published online Epub.
   PubMed Web of Science ®Google Scholar
• Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012 Mar 25;13:465–473.
   PubMed Web of Science ®Google Scholar
• Qin X, Hoda MN, Susin C, et al. Increased innate lymphoid cells in periodontal tissue of the murine model of Periodontitis: the role of AMP-activated protein Kinase and relevance for the human condition. Front Immunol. 2017;8:922.
   Web of Science ®Google Scholar
• Rashid MH, Borin TF, Ara R, et al. Differential in vivo biodistribution of (131)I-labeled exosomes from diverse cellular origins and its implication for theranostic application. Nanomed. 2019 Aug 1;21:102072.
   PubMed Web of Science ®Google Scholar
• Elsayed R, Abraham P, Awad ME, et al. Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function. Bone. 2018 May;110:141–149. published online Epub.
   Web of Science ®Google Scholar
• Lee CT, Teles R, Kantarci A. Resolvin E1 reverses experimental Periodontitis and Dysbiosis. J Immunol. 2016 Oct 1;197:2796–2806. published online Epub.
   Google Scholar
• Li X, Li X, Lin J, et al. Exosomes derived from low-intensity pulsed ultrasound-treated Dendritic cells suppress tumor necrosis factor-induced Endothelial inflammation. J Ultrasound Med. 2018 Dec 18. published online Epub. DOI:10.1002/jum.14898
   Web of Science ®Google Scholar
• Colombo M, Raposo G, Thery C. Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol. 2014;30:255–289.
   PubMed Web of Science ®Google Scholar
• McKelvey KJ, Powell KL, Ashton AW, et al. Exosomes: mechanisms of Uptake. J Circ Biomark. 2015;4:7.
   PubMedGoogle Scholar
• Nazarenko I, Rupp AK, Altevogt P. Exosomes as a potential tool for a specific delivery of functional molecules. Methods Mol Biol. 2013;1049:495–511.
   PubMedGoogle Scholar
• Yee D, Shah KM, Coles MC, et al. MicroRNA-155 induction via TNF-alpha and IFN-gamma suppresses expression of programmed death ligand-1 (PD-L1) in human primary cells. J Biol Chem. 2017 Dec 15;292:20683–20693.
   Web of Science ®Google Scholar
• Morelli AE, Larregina AT, Shufesky WJ, et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood. 2004 Nov 15;104:3257–3266.
   PubMed Web of Science ®Google Scholar
• Cools N, Van Tendeloo VF, Smits EL, et al. Immunosuppression induced by immature dendritic cells is mediated by TGF-beta/IL-10 double-positive CD4+ regulatory T cells. J Cell Mol Med. 2008 Apr;12:690–700. published online Epub.
   PubMed Web of Science ®Google Scholar
• Oh K, Kim YS, Lee DS. Maturation-resistant dendritic cells ameliorate experimental autoimmune uveoretinitis. Immune Netw. 2011 Dec;11:399–405. published online Epub.
   PubMedGoogle Scholar
• Sun X, Gong ZJ, Wang ZW, et al. IDO-competent-DCs induced by IFN-gamma attenuate acute rejection in rat liver transplantation. J Clin Immunol. 2012 Aug;32:837–847. published online Epub.
   Web of Science ®Google Scholar
• Arizon M, Nudel I, Segev H, et al. Langerhans cells down-regulate inflammation-driven alveolar bone loss. Proc Nat Acad Sci. 2012;109:7043–7048.
   Web of Science ®Google Scholar
• Riley JL, June CH, Blazar BR. Human T regulatory cell therapy: take a billion or so and call me in the morning. Immunity. 2009;30:656–665.
   PubMed Web of Science ®Google Scholar
• Trzonkowski P, Bacchetta R, Battaglia M, et al. Hurdles in therapy with regulatory T cells. Sci Transl Med. 2015;7:304ps318–304ps318.
   Web of Science ®Google Scholar
• Alissafi T, Banos A, Boon L, et al. Tregs restrain dendritic cell autophagy to ameliorate autoimmunity. J Clin Invest. 2017 Jun 30;127:2789–2804.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Xiang X, Grizzle W, et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011;19:1769–1779.
   PubMed Web of Science ®Google Scholar
• Sun D, Zhuang X, Xiang X, et al. A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther. 2010;18:1606–1614.
   PubMed Web of Science ®Google Scholar
• Escudier B, Dorval T, Chaput N, et al. Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med. 2005 Mar 2;3:10.
   PubMed Web of Science ®Google Scholar
• Morse MA, Garst J, Osada T, et al. A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med. 2005 Feb 21;3:9.
   PubMed Web of Science ®Google Scholar
• C. M, Besse B, Lapierre V, et al. Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC. Oncoimmunology. 2016;5:e1071008.
   Web of Science ®Google Scholar
• W. D, Dai S, Wu Z, et al. Phase I clinical trial of autologous ascites-derived exosomes combined with GM-CSF for colorectal cancer. Mol Ther. 2008;16:782–790.
   Web of Science ®Google Scholar
• Tran DQ. TGF-β: the sword, the wand, and the shield of FOXP3+ regulatory T cells. J Mol Cell Biol. 2011;4:29–37.
   Web of Science ®Google Scholar
• Ihara S, Hirata Y, Koike K. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. J Gastroenterol. 2017;52:777–787.
   PubMed Web of Science ®Google Scholar
• Guo B. IL-10 modulates Th17 pathogenicity during autoimmune diseases. J Clin Cell Immunol. 2016;7. doi:10.4172/2155-9899.1000400
   Google Scholar
• Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev™ Immunol. 2012;32: 23–63.
   Web of Science ®Google Scholar
• Shelke GV, Yin Y, Jang SC, et al. Endosomal signalling via exosome surface TGFbeta-1. J Extracell Vesicles. 2019;8:1650458.
   PubMed Web of Science ®Google Scholar
• Jakhar R, Crasta K. Exosomes as emerging pro-tumorigenic mediators of the senescence-associated secretory phenotype. Int. J. Mol. Sci. 2019 May 24;20:2547.
   Web of Science ®Google Scholar
• Ringuette Goulet C, Bernard G, Tremblay S, et al. Exosomes induce fibroblast differentiation into cancer-associated fibroblasts through TGFbeta signaling. Mol Cancer Res. 2018 Jul;16:1196–1204. published online Epub.
   PubMed Web of Science ®Google Scholar
• van Dongen HM, Masoumi N, Witwer KW, et al. Extracellular vesicles exploit viral entry routes for cargo delivery. Microbiol Mol Biol Rev. 2016 Jun;80:369–386. published online Epub.
   PubMed Web of Science ®Google Scholar
• Mulcahy LA, Pink RC, Carter DR. Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles. 2014;3:24641.
   PubMedGoogle Scholar
• Cai Z, Zhang W, Yang F, et al. Immunosuppressive exosomes from TGF-β1 gene-modified dendritic cells attenuate Th17-mediated inflammatory autoimmune disease by inducing regulatory T cells. Cell Res. 2012;22:607.
   PubMed Web of Science ®Google Scholar
• Yu L, Yang F, Jiang L, et al. Exosomes with membrane‐associated TGF‐β1 from gene‐modified dendritic cells inhibit murine EAE independently of MHC restriction. Eur J Immunol. 2013;43:2461–2472.
   PubMed Web of Science ®Google Scholar
• Eskan MA, Jotwani R, Abe T, et al. The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol. 2012;13:465.
   PubMed Web of Science ®Google Scholar
• Moutsopoulos NM, Konkel J, Sarmadi M, et al. Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17–driven inflammatory bone loss. Sci Transl Med. 2014;6:229ra240–229ra240.
   Web of Science ®Google Scholar
• Kim YG, Lee CK, Nah SS, et al. Human CD4+CD25+ regulatory T cells inhibit the differentiation of osteoclasts from peripheral blood mononuclear cells. Biochem Biophys Res Commun. 2007 Jun 15;357:1046–1052.
   Web of Science ®Google Scholar
• Kong N, Lan Q, Su W, et al. Induced T regulatory cells suppress osteoclastogenesis and bone erosion in collagen-induced arthritis better than natural T regulatory cells. Ann Rheum Dis. 2012 Sep;71:1567–1572. published online Epub.
   Web of Science ®Google Scholar
• Cha W, Fan R, Miao Y, et al. MicroRNAs as novel endogenous targets for regulation and therapeutic treatments. Medchemcomm. 2018 Mar 1;9:396–408.
   Web of Science ®Google Scholar